FDAAA Impact Analysis: Year One
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
If you want to market a new pharmaceutical or vaccine ingredient in the U.S., you should consult a copy of the 2007 Food & Drug Administration Amendments Act